b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">29996538</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2077-0383</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>7</Volume>\n                    <Issue>7</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Jul</Month>\n                        <Day>10</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of clinical medicine</Title>\n                <ISOAbbreviation>J Clin Med</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E172</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm7070172</ELocationID>\n            <Abstract>\n                <AbstractText>B7-H3 (CD276), a member of the family of immune modulators, orchestrates antitumor immunity. To date, only small-sized studies have examined the association of B7-H3 expression with survival in pancreatic cancer, yielding inconclusive results. We evaluated tumor B7-H3 expression in 150 consecutive patients with pancreatic ductal adenocarcinoma using immunohistochemistry. B7-H3 expression was positive (&amp;ge;10% tumor cells) in 99 of 150 (66%) cases of pancreatic cancer. We classified the tumors into four groups depending on B7-H3 expression (negative, low, intermediate, and high) and found that higher B7-H3 expression was independently associated with lower disease-free survival (DFS; for high vs. negative B7-H3 expression: multivariable hazard ratio (HR) = 3.12; 95% confidence interval (CI) = 1.48\xe2\x81\xbb6.15; <i>P</i><sub>trend</sub> = 0.0026). Furthermore, the association of B7-H3 expression with survival differed according to the pathological stage (p-stage) (<i>P</i><sub>interaction</sub> = 0.048, between p-stages I\xe2\x81\xbbII and III\xe2\x81\xbbIV). The association of B7-H3 positivity with lower DFS was stronger in tumors with p-stage I\xe2\x81\xbbII (multivariable HR = 3.10, 95% CI = 1.75\xe2\x81\xbb5.69; <i>P</i> &lt; 0.0001) than in those with p-stage III\xe2\x81\xbbIV (multivariable HR = 1.20, 95% CI = 0.67\xe2\x81\xbb2.28; <i>P</i> = 0.55). We demonstrated that tumor high B7-H3 expression is independently associated with poor survival in patients with pancreatic cancer and that this association is stronger in tumors with p-stage I\xe2\x81\xbbII than in those with p-stage III\xe2\x81\xbbIV. B7-H3 expression may be a useful prognostic biomarker for identifying aggressive early-stage pancreatic cancer.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Inamura</LastName>\n                    <ForeName>Kentaro</ForeName>\n                    <Initials>K</Initials>\n                    <Identifier Source="ORCID">0000-0001-6444-3861</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. kentaro.inamura@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Takazawa</LastName>\n                    <ForeName>Yutaka</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. yutaka.takazawa@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Inoue</LastName>\n                    <ForeName>Yosuke</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of hepato-biliary-pancreatic surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. yosuke.inoue@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yokouchi</LastName>\n                    <ForeName>Yusuke</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Biomarker Department, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan. lalalagamy@nifty.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kobayashi</LastName>\n                    <ForeName>Maki</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. maki.kobayashi@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Saiura</LastName>\n                    <ForeName>Akio</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of hepato-biliary-pancreatic surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. akio.saiura@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shibutani</LastName>\n                    <ForeName>Tomoko</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Biomarker Department, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan. shibutani.tomoko.zc@daiichisankyo.co.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ishikawa</LastName>\n                    <ForeName>Yuichi</ForeName>\n                    <Initials>Y</Initials>\n                    <Identifier Source="ORCID">0000-0001-6444-3861</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. ishikawa@jfcr.or.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>10</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>J Clin Med</MedlineTA>\n            <NlmUniqueID>101606588</NlmUniqueID>\n            <ISSNLinking>2077-0383</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">B7-H3</Keyword>\n            <Keyword MajorTopicYN="N">clinical outcome</Keyword>\n            <Keyword MajorTopicYN="N">immune checkpoint inhibitor</Keyword>\n            <Keyword MajorTopicYN="N">immune modulator</Keyword>\n            <Keyword MajorTopicYN="N">immunotherapy</Keyword>\n            <Keyword MajorTopicYN="N">pancreatic ductal adenocarcinoma</Keyword>\n            <Keyword MajorTopicYN="N">prognosis</Keyword>\n            <Keyword MajorTopicYN="N">tumor microenvironment</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29996538</ArticleId>\n            <ArticleId IdType="pii">jcm7070172</ArticleId>\n            <ArticleId IdType="doi">10.3390/jcm7070172</ArticleId>\n            <ArticleId IdType="pmc">PMC6069252</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer Cell. 2017 Apr 10;31(4):501-515.e8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28399408</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2018 Jul 1;425:143-151</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29605510</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2017 Nov 23;551(7681):512-516</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29132146</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Sep 21;8(54):93156-93167</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29190985</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lung Cancer. 2017 Jan;103:44-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28024695</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2017 Feb 15;140(4):948-958</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27813059</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Structure. 2013 May 7;21(5):707-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23583036</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Hematol Oncol. 2018 Mar 15;11(1):39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29544515</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunother. 2010 Oct;33(8):828-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20842054</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2017 Jan;67(1):7-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28055103</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2014 Jul 8;111(1):149-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24892449</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Jpn J Clin Oncol. 2016 Oct;46(10):935-941</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27511990</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Med. 2013 Feb;31(2):283-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23242015</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2016 Oct 10;381(1):244-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26723878</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2018 May 18;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29788230</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2016 Jul 15;22(14):3425-3431</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27208063</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Immunol. 2013 Apr;25(2):200-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23422836</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell Int. 2013 Aug 16;13(1):81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23947693</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2009 Nov 17;101(10):1709-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19844235</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2018 May 14;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29756386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2001 Mar;2(3):269-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11224528</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lung Cancer. 2010 Oct;70(1):94-102</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20117855</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3769-E3778</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29615514</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gastrointest Oncol. 2016 Jun;7(3):487-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27284483</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2014 Aug 19;7:1465-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25170273</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancers (Basel). 2018 Jan 03;10(1):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29301364</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2016 Mar;11(3):1841-1846</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26998087</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancers (Basel). 2018 Jan 30;10(2):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29385739</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2018 May 24;378(21):1976-1986</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29658848</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2014 Sep 11;371(11):1039-49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25207767</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2014 Jun 15;134(12):2764-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24013874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Pathol. 2008;3:157-88</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18039136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Oncol Rep. 2018 May 8;20(7):55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29740718</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2009 Dec 26;9:463</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20035626</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2012 Jun 12;21(6):836-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22698407</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Aug 24;8(43):74856-74868</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29088829</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2014 Aug 20;14:602</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25139714</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol. 2002 Jun 15;168(12):6294-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12055244</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2012 Jun 28;366(26):2455-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22658128</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancers (Basel). 2018 Jan 27;10(2):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29382042</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2018 Apr 16;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29661773</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2018 Jun 1;24(11):2653-2664</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29530936</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'